Dumontiaceae

Dumontiaceae: A Taxonomic and Scientific Reference

1. Identity and Taxonomy

Dumontiaceae is a family of red macroalgae (seaweeds) within the phylum Rhodophyta. Dumontiaceae is a family of red algae. In formal systematic terms, Dumontiaceae belongs to the order Gigartinales within the class Florideophyceae, subclass Rhodymeniophycidae. The family was established using cladistic analysis of morphological and, more recently, molecular characters.

The family Dumontiaceae contains 24 genera (19 of which contain currently recognized species) and is reportedly primarily cool- and cold-temperate in distribution. Among the genera distributed in the Pacific Northwest of North America, recognized members of Dumontiaceae include Cryptosiphonia, Dilsea, Dumontia, Farlowia, Neodilsea, Orculifilum, Pikea, Sarcophyllis, and Thuretellopsis. Hawaiian representatives studied using molecular phylogenetics include the genera Dudresnaya and Gibsmithia, with a new species, Gibsmithia punonomaewa, reported from mesophotic depths (79–104 m) of the Papahānaumokuākea Marine National Monument, Hawaiʻi.

The tribe Dumontieae, resurrected by taxonomic analysis within the family, consists of the species of Dumontia, Cryptosiphonia, Hyalosiphonia, Masudaphycus gen. nov., Neodilsea, and Dilsea, all found in the North Pacific with some spillover into the North Atlantic.

The type genus, Dumontia, was formally described in 1813. Dumontia is a genus of red algae belonging to the family Dumontiaceae, with species found in Eurasia, Northern America and Australia. The species Dumontia contorta (Gmelin) Ruprecht has a complex nomenclatural history: Dumontia contorta (Gmelin) Ruprecht is the earliest available name for the widely distributed northern hemisphere red alga, D. incrassata (Müller) Lamouroux, which has also been incorrectly known as D. filiformis (Hornemann) Greville and D. filiformis (Lyngbye) J. Agardh.

Of the algae in the family most relevant to food and supplement use, Dilsea carnosa is the most historically documented species. Dilsea carnosa, commonly known as the poor man's weather glass or the sea belt, is a species of red algae in the Dumontiaceae family of the order Gigartinales. The species was first described scientifically by Schmidel in 1794, under the name Fucus carnosus. The German botanist Otto Kuntze transferred the species to Dilsea in 1898. Morphologically, Dilsea carnosa is a large alga that is dark red, flattened and somewhat leathery; it may be 30 cm or more long and 15 cm wide, is usually not branched but may split, and grows from a small discoid base. Its geographic range extends from the British Isles, being more abundant in the south of England, to Arctic Russia and Portugal.

The genus Dilsea contains two species: D. carnosa (Schmidel) Kuntze (1898) and D. californica (J. Agardh) Kuntze (1891); the genus Neodilsea Tokida encompasses six species including N. americana, N. crispata, N. integra, N. natashae, N. tenuipes, and N. yendoana.

Another notable member of the family is Pikea californica, described from the Pacific coast. Pikea californica Harvey belongs to Phylum Rhodophyta, Class Florideophyceae, Order Gigartinales, Family Dumontiaceae, with a thallus 5–10 cm tall, bushy, with main branches 1–1.5 mm wide with pointed, pinnate side branches and a dark red to blackish coloration when dry.

2. Morphological and Biological Characteristics

Dumontiaceae members are macroscopic red seaweeds with complex, triphasic life histories characteristic of the class Florideophyceae. Red algal life histories are complex and typically comprise three stages: a diploid tetrasporophyte that undergoes meiosis to produce haploid tetraspores, which are released and settle to grow into haploid male or female gametophytes. Gametophytes may look identical or very different (heteromorphic) from the tetrasporophyte phase from which they arose. Males and females produce gametes via simple mitosis; males release non-motile spermatia which find and fertilize ova that are retained by the female. The fertilized diploid zygote grows into the third generation, the carposporophyte, firmly attached to the haploid female. Eventually, the carposporophyte releases diploid carpospores that grow into tetrasporophytes and the cycle begins again.

Within the Dumontieae tribe, morphological trends have been well characterized: trends in the Dumontieae include a change from a uniaxial, cylindrical, branched habit to a 'multiaxial', foliose habit and development of a large gonimoblast fusion cell and large sporangia that diminish in size with evolutionary advancement within the tribe.

Dilsea carnosa grows in specific marine habitats: it produces dark carmine red, frequently becoming yellow-green at apices, thick, flattened cartilaginous fronds, arising in groups from a thick discoid holdfast, obtuse and ovate with tapered base, to 500 mm long and 250 mm broad. Stands probably persist for many years as the disk produces new blades continuously. The habitat is on rock in shady pools, lower intertidal on rock, and shallow subtidal to 25 m, usually on rock in kelp forests.

3. Traditional and Historical Use

The use of red macroalgae including species from Dumontiaceae and related families as human food in Europe has deep roots but is poorly documented relative to East Asian seaweed traditions. Evidence of consumption of seaweed resources extends through the Neolithic transition to farming and into the Early Middle Ages, suggesting that these resources, now rarely eaten in Europe, only became marginal much more recently. Understanding ancient foodstuffs is crucial to reconstructing the past, while a better knowledge of local, forgotten resources is likewise important today.

Seaweed's presence on archaeological sites has been related to non-edible uses including fuel, food wrappings, fertiliser and cramp linked to gathering bone fragments during cremation. A text attributed to St Columba (521–597 AD) recounts collecting dulse (red seaweed) in Scotland. Historical accounts report laws related to collection of seaweed in Iceland, Brittany and Ireland dating to the 10th century AD and the broad use of seaweed as animal fodder in northwest Europe. By the 18th century seaweed was considered as famine food even in the Scottish islands, although some coastal regions still consume seaweed today.

Among Dumontiaceae members, Dilsea carnosa has a notable vernacular history. The name "dulse" was historically applied to the edible purplish-brown seaweeds Rhodymenia palmata and Dilsea carnosa, used in soups and jellies. Despite this culinary history, current assessments are more cautious: Dilsea carnosa is also known as D. edulis and as "False dulse," and it is now considered not edible. The species is not recommended for eating as it contains suspect compounds. It is commonly confused with the genuinely edible dulse, Palmaria palmata: Dilsea carnosa is another red seaweed, however it is more leathery and its fronds can grow up to 30 cm long and 20 cm wide. It is not branched, but older plants can split.

In Asia, seaweed consumption has been a cultural cornerstone for centuries. For centuries, macroalgae, or seaweeds, have been a significant part of East Asian diets. However, this tradition does not specifically pertain to Dumontiaceae species, which are primarily cool-temperate and North Pacific/North Atlantic in distribution. In Europe, seaweeds are not considered traditional foods, even though they are increasingly popular in Western diets in human food applications.

Important note on traditional use: No verified record of Dumontiaceae species being used as a formalized medicinal preparation in any traditional medicine system (Ayurveda, Traditional Chinese Medicine, European phytomedicine, or Indigenous North American medicine) was located in peer-reviewed or government sources for the purposes of this article. Claims that circulate in supplement marketing about traditional use of "Dumontiaceae" as a named ingredient should be treated with caution, as this is a taxonomic family designation rather than a traditional-use category.

4. Key Constituents and Active Compounds

As members of the class Rhodophyta (red algae), Dumontiaceae species share the general biochemical profile of red macroalgae, which has been characterized in the scientific literature. The major classes of bioactive compounds include sulfated polysaccharides, phycobiliproteins, and polyunsaturated fatty acids.

4.1 Sulfated Polysaccharides

Marine algae are rich in sulfated polysaccharides (SPs) such as carrageenans in red algae, fucoidans in brown algae and ulvans in green algae. Sulfated polysaccharides (SPs) isolated from seaweed have emerged as remarkable bioactive compounds with a wide spectrum of biological activities. The diverse biological activities of SPs include anticoagulant, anti-inflammatory, antiviral, antioxidant, and immunomodulatory properties, which underpin their potential health benefits.

Carrageenans are among the most commercially significant polysaccharides from red algae. There are three main commercial classes of carrageenan: κ-, ι- and λ-carrageenans. κ-type may have galactose units esterified with sulfate at the 4-position; κ- and ι-carrageenans contain significant amounts of 3,6-anhydro-D-galactose residues and can undergo thermally reversible gelation in the presence of potassium and certain other cations; while the λ-type contains smaller amounts to none. Each type of carrageenan exhibits distinct gelling properties and is found in distinct concentrations within red algal cell walls. The amount of a particular kind of carrageenan varies taxonomically, with life-cycle phases, biotic and abiotic factors.

With respect to digestibility, due to their chemical nature as complex polysaccharides, carrageenans cannot be digested by the human digestive tract, although they can be fermented by the colonic microbiota. On these bases, to date, these substances are not known for their potential to be added to the human diet.

The anticoagulant mechanism of seaweed sulfated polysaccharides has been studied at the biochemical level: for anticoagulation potency, the formation of the SP/protease protein complex and the associated non-specific polar interaction between the negatively and positively charged groups in the polysaccharide and protein is responsible for anticoagulant activity. The anticoagulant activity is mainly attributed to thrombin inhibition mediated by heparin cofactor II, with different effectiveness depending on the compound.

4.2 Phycobiliproteins

Red algae, including members of Dumontiaceae, contain characteristic photosynthetic pigment-protein complexes called phycobiliproteins. Phycobiliproteins are a family of light-harvesting pigment-protein complexes found widely in cyanobacteria, red algae and some cryptomonads. According to their light absorption properties, phycobiliproteins are classified into three main groups: phycoerythrin (PE; λmax = 565–567 nm), phycocyanin (PC; λmax = 615–620 nm) and allophycocyanin (AP; λmax = 650–652 nm).

According to the species, different forms exist: R-phycoerythrin (R-PE) for Rhodophytes, B-phycoerythrin and b-phycoerythrin (B-PE and b-PE) for Bangiales, and C-phycoerythrin (C-PE) for Cyanophyceae. R-phycoerythrin is the most abundant in Rhodophytes.

Phycobiliproteins are hydrophilic groups of pigment-proteins from red macroalgae and have antioxidant ability in vitro and in vivo toward free radicals and selenium. Phycobiliproteins from red macroalgal species have an important role as anticancer agents, due to their high efficiency and low toxicity. Phycobiliproteins are commercially used for their therapeutic value as anti-inflammatory agents. R-phycoerythrin from most red seaweed such as Gelidium pusillum, Chondrus crispus, and Gracilaria verrucosa exhibited anti-inflammatory capacity. Phycocyanin exhibited anti-inflammatory activity with antioxidative ability.

Beyond their biological activity, phycobiliproteins also have commercial applications: phycobiliproteins are currently added as a natural coloring pigment in cosmetics and in foods such as chewing gum and certain dairy products. Various phycobiliproteins have several features such as hepatoprotective, anti-inflammatory, antitumor, hypocholesterolemic, antiviral, neuroprotective, antioxidant, and lipase inhibition activities.

4.3 Polyunsaturated Fatty Acids

Although the total lipid content is low (1–5% dry weight), seaweeds are a unique plant source of omega-3 long-chain fatty acids, notably EPA and DHA, which support cognitive function and promote anti-inflammatory balance. PUFA from red seaweed had anti-thrombotic and anti-inflammatory properties. The n-6/n-3 ratio between fatty acids should be less than 10 in the diet, which may prevent cardiovascular, inflammatory, and nervous system disorders.

4.4 Proteins and Dietary Fiber

Protein content in red algae can reach as high as 47% of dry weight. Dietary fiber accounts for up to 75% of seaweed's dry mass, dominated by soluble polysaccharides like fucoidan, alginate, and carrageenan, which act as prebiotics that modulate gut microbiota.

5. Scientific Evidence by Area of Use

Critical context: It is essential to state that no peer-reviewed human clinical trials were identified in authoritative sources (PubMed/PMC, Cochrane, NIH, EFSA, WHO) that specifically and exclusively studied extracts or preparations of Dumontiaceae family members as a defined supplement intervention. "Dumontiaceae" as a family designation does not correspond to a commercially standardized extract for which specific clinical trial data exist. The following evidence pertains to the broader category of red macroalgae (Rhodophyta) and, where specified, closely related genera within Gigartinales. All evidence strength assessments reflect this broader context.

5.1 Antioxidant Activity

Antioxidant properties of red algal compounds have been documented extensively in laboratory (in vitro) studies. Phycobiliproteins have antioxidant ability in vitro and in vivo toward free radicals and selenium. R-phycoerythrin from Mastocarpus stellatus has demonstrated antioxidant ability.

Sulfated polysaccharides (e.g., carrageenan, porphyran) suppress NF-κB-mediated neuroinflammation, modulate mitochondrial function, and enhance brain-derived neurotrophic factor (BDNF) expression. Phycobiliproteins (phycoerythrin, phycocyanin) and peptides derived from their degradation scavenge reactive oxygen species (ROS) and activate antioxidant pathways (e.g., Nrf2/HO-1), thus mitigating oxidative damage.

Evidence strength: Predominantly in vitro and animal model data. No specific human clinical trials establishing antioxidant efficacy of Dumontiaceae preparations in vivo were identified.

5.2 Anti-inflammatory Activity

The anti-inflammatory potential of red algae compounds has been investigated in preclinical studies. The biological activities of sulfated polysaccharides include anti-inflammatory properties, which underpin their potential health benefits. Phycobiliproteins are commercially used for their therapeutic value as anti-inflammatory agents. R-phycoerythrin from most red seaweed exhibited anti-inflammatory capacity.

Evidence strength: Preclinical (in vitro and animal) only for Dumontiaceae-adjacent taxa. No human clinical trial data specific to Dumontiaceae were found.

5.3 Anticoagulant and Cardiovascular Effects

Sulfated polysaccharides from marine algae exhibit many health beneficial nutraceutical effects such as antioxidant, anti-allergic, anti-human immunodeficiency virus, anticancer and anticoagulant activities. The proposed mechanism at the biochemical level involves thrombin inhibition: the formation of the SP/protease protein complex and the associated non-specific polar interaction between the negatively and positively charged groups in the polysaccharide and protein is responsible for anticoagulant activity. The anticoagulant activity is mainly attributed to thrombin inhibition mediated by heparin cofactor II.

Evidence strength: In vitro mechanistic data only. Translation to human clinical outcomes for Dumontiaceae-derived compounds specifically has not been established in the sourced literature.

5.4 Immunomodulatory Activity

The biological activities of sulfated polysaccharides from seaweed include immunomodulatory properties. Bioactive polysaccharides from marine algae can have a variety of therapeutic properties, including antioxidant, antitumor, immunomodulatory, anti-inflammatory, anticoagulation, antiviral, antiprotozoan, antibacterial, antilipemic, or other bioactive properties.

Evidence strength: In vitro and animal model data predominate. No human clinical trials specific to Dumontiaceae members were found.

5.5 Antitumor and Anticancer Activity

Phycobiliproteins from red macroalgal species have an important role as anticancer agents, due to their high efficiency and low toxicity. At the molecular level, carotenoids (lutein, zeaxanthin) improve cognitive function through the inhibition of acetylcholinesterase and pro-inflammatory cytokines (TNF-α, IL-1β), while phenolic compounds (bromophenols, diphlorethol) provide protection by targeting multiple pathways.

Evidence strength: In vitro and in vivo (rodent) model data only. No clinical trial evidence for anticancer activity of Dumontiaceae preparations in humans was identified in reviewed sources.

5.6 Gut Microbiota / Prebiotic Effects

Dietary fiber in seaweeds is dominated by soluble polysaccharides like fucoidan, alginate, and carrageenan, which act as prebiotics that modulate gut microbiota. Studies confirm that these fibers stimulate beneficial bacterial genera and increase short-chain fatty acid (SCFA) production, which in turn influences brain and immune health. However, it must be noted that due to their chemical nature as complex polysaccharides, carrageenans cannot be digested by the human digestive tract, although they can be fermented by the colonic microbiota.

Evidence strength: Mechanistic and limited human dietary studies in the context of the broader seaweed category. No Dumontiaceae-specific human clinical trials were identified.

5.7 Neuroprotective Potential

Bioactive compounds derived from red algae, including polysaccharides and phycobiliproteins, are considered a promising source of natural therapeutics. Red algal constituents exhibit neuroprotective activities through multiple mechanisms. Sulfated polysaccharides (e.g., carrageenan, porphyran) suppress NF-κB-mediated neuroinflammation, modulate mitochondrial function, and enhance brain-derived neurotrophic factor (BDNF) expression.

Evidence strength: Early-stage, primarily preclinical. No human clinical data exist for Dumontiaceae preparations specifically.

6. Body Systems and Health Areas of Association

Based on the biochemical profile documented for red macroalgae more broadly, Dumontiaceae species have been associated in the literature — at the preclinical level — with the following body systems and health areas:

• Cardiovascular system: Anticoagulant sulfated polysaccharides; PUFA with anti-thrombotic and anti-inflammatory properties.
• Immune system: Immunomodulatory sulfated polysaccharides; phycobiliprotein-based immune enhancement.
• Gastrointestinal tract: Prebiotic fiber (carrageenan, other polysaccharides) fermented by colonic microbiota; short-chain fatty acid production.
• Oxidative stress / antioxidant defense: Phycoerythrin, phycocyanin, and other phycobiliproteins acting as ROS scavengers; Nrf2/HO-1 pathway activation.
• Inflammation: NF-κB inhibition by sulfated polysaccharides; anti-inflammatory PUFA (EPA/DHA).
• Neurological system: Neuroprotective potential of phycobiliproteins and sulfated polysaccharides in Alzheimer's disease models (preclinical only).
• Cancer biology: Anticancer activity of phycobiliproteins and sulfated polysaccharides (in vitro/animal only).

7. Dosage Forms and Reported Dosages

No standardized dosage forms or specific dosages for Dumontiaceae-family preparations were identified in any peer-reviewed clinical trial or regulatory monograph retrieved during the preparation of this article. The current scientific literature explores the complicated properties of sulfated polysaccharides from seaweed, with their extraction methodologies and techniques for precise characterization, emphasizing their importance in human well-being. However, no dose-ranging studies or established therapeutic doses for Dumontiaceae species specifically exist in the reviewed literature.

In the context of general seaweed supplementation research, researchers have evaluated the use of various seaweeds to supplement food products at 0–1.0% dehydrated seaweed. For food fortification applications, seaweeds have been evaluated at doses of 5–15% to develop functional products such as breadsticks. These figures pertain to food fortification studies and do not represent clinical dosing for Dumontiaceae specifically.

In European regulations, seaweeds are included in the "novel foods" category as they are not considered a traditional food, and they represent a marginal market compared with other traditional European foods, although they are increasingly exploited for the production of ingredients and thus becoming popular in western diets.

8. Safety Considerations and Interactions

8.1 Heavy Metals and Inorganic Contaminants

Seaweeds, as bioaccumulators from the marine environment, carry documented contamination risks. The relevance of seaweeds and seaweed-related products for the exposure to arsenic, cadmium, mercury and lead has been assessed; for cadmium and total arsenic, the highest mean exposure from the consumption of seaweeds in 'consumers only' was similar to the estimates reported in previous exposure assessments considering the whole diet. The high cadmium exposure was linked to the relatively high levels reported in the dried red algae Laver (1,675–1,676 μg/kg). For lead and inorganic arsenic, dietary exposure estimates from seaweed consumption in 'consumers only' were considered non-negligible since they represented between 10 and 30% of the total exposure in previous EFSA assessments.

Regulatory standards require seaweed preparations to contain not more than 20 ppm heavy metals and not more than 5 ppm arsenic.

8.2 Iodine Content

Iodine is a significant safety consideration with any red algae supplement. A 2025 Korean nationwide study found average iodine levels of 2,432 mg/kg dry weight in sea tangle (Saccharina japonica), compared to less than 200 mg/kg in most red and green algae. In some species, a one-gram serving may deliver over 4,000 µg of iodine, about seven times the EFSA upper intake level of 600 µg/day. Red algae in general have significantly lower iodine content than major brown algae such as kelp, but the risk is not zero, particularly with concentrated supplement preparations.

8.3 Carrageenan Safety Distinction

Red algal preparations that contain carrageenan require attention to the form of carrageenan present. Food-grade carrageenan is different from, and should not be confused with, degraded carrageenan, which is a known carcinogen. This distinction between native (undegraded, food-grade) carrageenan and poligeenan (degraded carrageenan) is a consistent concern in safety assessments of red algal products.

8.4 Edibility of Specific Dumontiaceae Members

Not all members of Dumontiaceae are edible. Dilsea carnosa is not recommended for eating as it contains suspect compounds; the name change from Iridaea edulis itself is indicative of the changing face of marine botany as modern science comes to better understand seaweeds. The species is easily confused with the edible Palmaria palmata (true dulse), and misidentification is a realistic hazard for wild harvesters.

8.5 Regulatory Status in Europe

In European regulations, seaweeds are included in the "novel foods" category as they are not considered a traditional food. This classification means that novel food authorization may be required for certain Dumontiaceae-derived ingredients when introduced into the EU market, and the evidentiary burden for safety has formal regulatory requirements under EU Regulation 2015/2283.

8.6 Overall Evidence Limitations

As noted throughout this article, no human clinical trials specifically and exclusively investigating Dumontiaceae preparations as supplements were identified in peer-reviewed literature, NIH, EFSA, WHO monographs, or ESCOP resources. The family is primarily a taxonomic grouping, and the supplement industry's use of "Dumontiaceae" as an ingredient name does not correspond to a single chemically standardized substance with a dedicated clinical trial record. All bioactivity claims associated with Dumontiaceae in commercial contexts derive either from the broader red algae literature or are extrapolations from closely related genera within Gigartinales.

References

• Lindstrom SC (1988). The Dumontieae, a resurrected tribe of red algae (Dumontiaceae, Rhodophyta). Phycologia 27(1):89–102.
• Encyclopedia of Life — Dumontiaceae. EOL.org.
• Wikipedia — Dumontia (alga). Wikimedia Foundation.
• Wikipedia — Dilsea carnosa. Wikimedia Foundation.
• Abbott IA (1979). Taxonomy and nomenclature of the type species of Dumontia Lamouroux (Rhodophyta). Taxon.
• Sherwood AR et al. (2022). A new species of Gibsmithia (Dumontiaceae, Rhodophyta) from mesophotic depths of the Papahānaumokuākea Marine National Monument, Hawai'i, USA. Phycologia 61(5).
• ResearchGate — A revision on the red alga Dilsea carnosa.
• Stanford SeaNet — Rhodophyta: Red Seaweeds.
• MarLIN — Dilsea carnosa (Red rags). Marine Life Information Network.
• Seaweed.ie — Dilsea carnosa (Schmidel) O. Kuntze.
• Colonese AC et al. (2023). Human consumption of seaweed and freshwater aquatic plants in ancient Europe. PMC.
• Pradhan B et al. (2012). Therapeutic importance of sulfated polysaccharides from seaweeds: updating the recent findings. PMC.
• Algae Journal — Functions and values of sulfated polysaccharides from seaweed (2023).
• Wijesekara I et al. (2013). Sulfated polysaccharides as bioactive agents from marine algae. International Journal of Biological Macromolecules.
• Pereira L (2020). Therapeutic Uses of Red Macroalgae. Molecules. PMC7583832.
• Wang T et al. (2025). Neuroprotective Mechanisms of Red Algae-Derived Bioactive Compounds in Alzheimer's Disease. Marine Drugs. PMC12298236.
• Vásquez V et al. (2022). Biological properties and potential of compounds extracted from red seaweeds. Phytochemistry Reviews.
• Pereira L et al. (2020). Seaweeds as a Functional Ingredient for a Healthy Diet. Marine Drugs. PMC7345263.
• Zhang J et al. (2015). Characteristics of an R-Phycoerythrin with Two γ Subunits Prepared from Red Macroalga Polysiphonia urceolata. PMC4364535.
• Sekar S et al. (2023). A Review on a Hidden Gem: Phycoerythrin from Blue-Green Algae. PMC9863059.
• EFSA (2023). Dietary exposure to heavy metals and iodine intake via consumption of seaweeds and halophytes in the European population. EFSA Journal.
• Cosmetic Ingredient Review (CIR) (2021). Safety Assessment of Red Algae-Derived Ingredients as Used in Cosmetics.
• Correia M et al. (2022). The Controlled Semi-Solid Fermentation of Seaweeds as a Strategy for Their Stabilization and New Food Applications. PMC9497830.
• Operation Supplement Safety (OPSS) / NIH — Sea moss in dietary supplements.
• Pacific Northwest Herbaria — Algae of the Pacific Northwest (Dumontiaceae species list).
• Bender DA. "Dulse." A Dictionary of Food and Nutrition. Encyclopedia.com.